CD73 is critical for the resolution of murine colonic inflammation

Margaret S Bynoe1, Adam T Waickman, Deeqa A Mahamed

  • 1Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA. msb76@cornell.edu

Insights

CD73 deficiency exacerbates inflammatory bowel disease. Mice lacking CD73 show increased susceptibility to colitis, impaired gut barrier function, and unresolved inflammation, highlighting CD73

Area of Science:

  • Immunology
  • Gastroenterology
  • Biochemistry

Background:

  • CD73 (ecto-5'-nucleotidase) is a GPI-linked enzyme.
  • It generates extracellular adenosine from AMP.
  • Adenosine modulates inflammation and protects tissues.

Purpose of the Study:

  • To investigate the role of CD73-derived adenosine in DSS-induced colitis.
  • To determine the impact of CD73 deficiency on intestinal inflammation and barrier integrity.

Main Methods:

  • Utilized CD73 knockout (CD73(-/-)) and wild-type (WT) mice.
  • Induced colitis using Dextran-Sulfate-Sodium (DSS).
  • Assessed weight loss, gut permeability, tight junction molecule expression, inflammatory markers (TLR9, IL-1β, TNF-α), and NF-κB activation.

Main Results:

  • CD73(-/-) mice showed increased susceptibility to DSS colitis.
  • Deficiency led to pronounced weight loss, delayed recovery, and increased gut permeability.
  • CD73(-/-) mice exhibited decreased tight junction expression, unresolved inflammation, elevated TLR9, IL-1β, TNF-α, and constitutive NF-κB activation.

Conclusions:

  • CD73 expression in the colon is crucial for controlling the severity and resolution of immune responses.
  • Adenosine generated by CD73 plays a protective role in intestinal inflammation.